Deep belly-fat notes 04
Tesamorelin visceral fat fell during HIV treatment
Scans show how much deep fat changed, how long it lasted, and who was studied.
Visceral fat lies deep beside the organs
Your belt may need another notch as the belly grows firm. Doctors call this visceral fat, meaning fat beside the organs. You can't pinch it like the softer fat under the skin. It lies near the liver and intestines.
Doctors tested tesamorelin during HIV care when deep belly fat had grown. Daily shots lowered that inner fat on scans. The outer layer changed little. The scan results below show what happened.
Tesamorelin trials kept finding a drop near the organs
Phase 3 means the final large test before approval. One followed 412 people taking HIV medicine. They got 2 milligrams per day.
Scans showed that fat beside the organs had shrunk. Doctors saw one blood fat, triglycerides, fall 50 milligrams per deciliter, or per tenth of a liter. Without the starting level, that figure can't show the size of the change by itself. IGF-1 rose too; this growth protein forms in the liver [1].
With longer care, belly fat stayed about 18% below its start [2]. Another study scanned 50 adults. Doctors marked a fat area that shrank by 42 square centimeters [6]. That is an area on an image, not inches from your waist.
In a 2024 trial, the marked area fell 25 square centimeters. The placebo group gained 14 square centimeters over 12 months [9]. A placebo is a shot with no medicine. All had HIV.
A 2026 review combined five trials [8]. A standard 95% check allowed for study doubt. Even then, organ-side fat was lower.
Scans also found more lean tissue, meaning body tissue that wasn't fat. The trials reported no serious medical events, such as a threat to life or a hospital stay. You can read that as a study limit, not a promise.
Tesamorelin changed deep fat more than outer fat
Tesamorelin lowered fat beside the organs [1][2]. It didn't remove much of the softer layer under the skin. Scans showed a clear difference between the two places.
That mattered during HIV care. Many people had thin arms and legs with larger bellies. Losing more limb fat could have worsened the uneven shape. Most change occurred deep inside the abdomen.
Deep belly fat changed more than pinchable fat
Growth hormone and IGF-1, a liver-made protein, help turn stored fat into fuel [1]. Organ-side fat changed more than outer fat [1][2]. That is why the scans changed inside the belly. The pinchable layer barely moved.
The change lasted only during treatment. After the shots stopped, the organ-side fat returned [2]. The body hadn't gained a lasting reset. Continued treatment was part of the finding.
A brief test in healthy men asked a different question. Their IGF-1 rose by 181 micrograms in a liter of blood; each microgram is a millionth of a gram [4]. The paper gave no starting level, so that number isn't a belly-fat goal. Blood-sugar control didn't worsen during the short test.
Five tesamorelin trials pointed to the same fat drop
A 2026 review combined five separate trials. Fat near the organs fell across them. A standard 95% check asked whether study doubt could erase the drop; the check still pointed to less fat. Scans also found more body tissue that wasn't fat [8].
The softer skin-level fat stayed much the same. The trials reported no medical event that threatened life or required a hospital stay. The studies ran from 2007 through 2024. Every trial involved people in HIV care whose organ-side fat had grown [8].
Tesamorelin was not tested for ordinary weight loss
In HIV trials, tesamorelin lowered organ-side belly fat over 26 weeks [1]. Researchers didn't test healthy adults seeking to lose weight [5]. The measured change involved fat beside the organs. It wasn't mainly the outer layer you can pinch.
Tesamorelin scan changes lasted while treatment continued
Scans measured less deep fat after 26 weeks. During treatment, the result held through 52 weeks. Belly fat stayed about 18% below its starting level [1][2]. Those study dates can't predict when you might notice a change.
Deep belly fat returned after tesamorelin stopped
Fat near the organs returned after trial volunteers stopped the shots [2]. Tesamorelin didn't give their bodies a lasting change in fat storage. The medicine lowered that fat only during treatment. When treatment ended, the measured benefit ended too.